Publications 2022


“Association of Blood Pressure Lowering Intensity With White Matter Network Integrity in Patients With Cerebral Small Vessel Disease.” CP Pflanz, MS Egle, JT O’Brien, RG Morris, TR Barrick, AM Blamire, GA Ford, D Tozer, HS Markus, on behalf of the PRESERVE study group. Neurology doi: 10.1212/WNL.0000000000201018 (2022).

“Imaging Characteristics of Choroid Plexuses in Presymptomatic Multiple Sclerosis.” VAG Ricigliano, C Louapre, E Poirion, A Colombi, A Yazdan Panah, A Lazzarotto, E Morena, E Martin, M Bottlaender, B Bodini, D Seilhean, B Stankoff. Neurol Neuroimmunol Neuroinflamm doi: 10.1212/NXI.0000000000200026 (2022).

“The Loss of Macular Ganglion Cells Begins from the Early Stages of Disease and Correlates with Brain Atrophy in Multiple Sclerosis Patients.” AM Pietroboni, L Dell’Arti, M Caprioli, M Scarioni, T Carandini, A Arighi, L Ghezzi, GG Fumagalli, MA De Riz, P Basilico, A Colombi, E Benatti, F Triulzi, E Scarpini, F Viola, D Galimberti. Multiple Sclerosis Journal doi: (2022).

“Optimized Multi‑Echo Gradient‑Echo Magnetic Resonance Imaging for Gray and White Matter Segmentation in the Lumbosacral Cord at 3T.” S Büeler, MC Yiannakas, Z Damjanovski, P Freund, MD Liechti, G David. Nature Scientific Reports doi: (2022).

“Assessment of T2 Lesion-Based Disease Activity Volume Outcomes in Predicting Disease Progression in Multiple Sclerosis Over 10 Years.” D Oship, D Jakimovski, N Bergsland, D Horakova, T Uher, M Vaneckova, E Havrdova, MG Dwyer, R Zivadinov. Multiple Sclerosis and Related Disorders doi: 10.1016/j.msard.2022.104187 (2022).

“Brain Atrophy Measurement over a MRI Scanner Change in Multiple Sclerosis.” T Sinnecker, S Schädelin, P Benkert, E Ruberte, M Amann, JM Liebe, Y Naegelin, J Müller, J Kuhle, T Derfuss, L Kappos, J Wuerfel, C Granziera, Ö Yaldizli. NeuroImage: Clinical doi: 10.1016/j.nicl.2022.103148 (2022).

“Choroid Plexus Volume in Multiple Sclerosis Predicts Expansion of Chronic Lesions and Brain Atrophy.” S Klistorner, MH Barnett, J Parratt, C Yiannikas, SL Graham, A Klistorner. Annals of Clinical and Translational Neurology doi: 10.1002/acn3.51644 (2022).

“Association of NOTCH3 Variant Position With Stroke Onset and Other Clinical Features Among Patients With CADASIL.” BPH Cho, AA Jolly, S Nannoni, D Tozer, S Bell, HS Markus. Neurology doi: 10.1212/WNL.0000000000200744 (2022).

“Prevalence and Predictors of Vascular Cognitive Impairment in Patients With CADASIL.” AA Jolly, S Nannoni, H Edwards, RG Morris, HS Markus. Neurology doi: 10.1212/WNL.0000000000200607 (2022).

“Cognitive Profile in Idiopathic Autonomic Failure: Relation with White Matter Hyperintensities and Neurofilament Levels.” I Cani, L Sambati, F Bartiromo, GM Asioli, S Baiardi, LMB Belotti, G Giannini, P Guaraldi, C Quadalti, L Romano, R Lodi, P Parchi, P Cortelli, C Tonon, G Calandra-Buonaura. Annals of Clinical and Translational Neurology doi: 10.1002/acn3.51567 (2022).

“GPR39 Deficiency Impairs Memory and Alters Oxylipins and Inflammatory Cytokines Without Affecting Cerebral Blood Flow in a High-Fat Diet Mouse Model of Cognitive Impairment.” TM Bah, EM Allen, M Garcia-Jaramillo, R Perez, Y Zarnegarnia, CM Davis, MB Bloom, AA Magana, J Choi, G Bobe, MM Pike, J Raber, CS Maier, NJ Alkayed. Frontiers in Cellular Neuroscience doi: 10.3389/fncel.2022.893030 (2022).

“Spontaneous Remyelination in Lesions Protects the Integrity of Surrounding Tissues over Time in Multiple Sclerosis.” VAG Ricigliano, M Tonietto, M Hamzaoui, E Poirion, A Lazzarotto, M Bottlaender, P Gervais, E Maillart, B Stankoff, B Bodini. European Journal of Neurology doi: 10.1111/ene.15285 (2022).

“Exploring In Vivo Multiple Sclerosis Brain Microstructural Damage Through T1w/T2w Ratio: a Multicentre Study.” M Margoni, E Pagani, A Meani, L Storelli, S Mesaros, J Drulovic, F Barkhof, H Vrenken, A Gallo, A Bisecco, D Pareto, J Sastre-Garriga, O Ciccarelli, M Yiannakas, J Palace, P Preziosa, MA Rocca, M Filippi. Journal of Neurology Neurosurgery and Psychiatry doi: 10.1136/jnnp-2022-328908 (2022).

“Plasma 24-hydroxycholesterol is Associated with Narrower Common Carotid Artery and Greater Flow Velocities in Relapsing Multiple Sclerosis.” D Jakimovski, R Zivadinov, L Pelizzari, C Dunne-Jaffe, RW Browne, N Bergsland, MG Dwyer, B Weinstock-Guttman, M Ramanathan. Multiple Sclerosis and Related Disorders (2022).

“Association of Slowly Expanding Lesions on MRI with Disability in People with Secondary Progressive Multiple Sclerosis. F Calvi, F Prados Carrasco, C Tur, DT Chard, J Stutters, F De Angelis, N John, T Williams, A Doshi, RS Samson, D MacManus, CA Gandini Wheeler-Kingshott, O Ciccarelli, J Chataway, F Barkhof. Neurology, doi:10.1212/WNL.0000000000200144 (2022).

“MR T2-Relaxation Time as an Indirect Measure of Brain Water Content and Disease Activity in NMOSD.” L Cacciaguerra, E Pagani, M Radaelli, S Mesaros,V Martinelli, J Ivanovic, J Drulovic, M Filippi, MA Rocca. Journal of Neurology Neurosurgery and Psychiatry (2022).

“A Tractometry Principal Component Analysis of White Matter Tract Network Structure and Relationships with Cognitive Function in Relapsing-Remitting Multiple Sclerosis.” D Jandric, GJM Parker, H Haroon, V Tomassini, N Muhlert, I Lipp. NeuroImage: Clinical 34 (2022).

“Characterizing the Time Course of Cerebrovascular Reactivity in Multiple Sclerosis.” JA Lincoln, KM Hasan, RE Gabr, JS Wolinsky. Journal of Neuroimaging (2022).

“The PASTIS Trial: Testing Tadalafil for Possible Use in Vascular Cognitive Impairment.” MMH Pauls, LR Binnie, P Benjamin, S Betteridge, B Clarke, MK Dhillon, R Ghatala, FAH Hainsworth, FA Howe, U Khan, C Kruuse, JB Madigan, B Moynihan, B Patel, AC Pereira, E Rostrup, ABY Shtaya, CA Spilling, S Trippier, R Williams, R Young, TR Barrick, JD Isaacs, AH Hainsworth. Alzheimer’s & Dementia (2022).

“Slowly Expanding Lesions Predict 9-Year Multiple Sclerosis Disease Progression.” P Preziosa, E Pagani, A Meani, L Moiola, M Rodegher, M Filippi, MA Rocca. Neurol Neuroimmunol Neuroinflamm 9 e1139 (2022).

“Test–Retest Reliability of Arterial Spin Labelling for Cerebral Blood Flow in Older Adults with Small Vessel Disease.” LR Binnie, MMH Pauls, P Benjamin, MK Dhillon, S Betteridge, B Clarke, R Ghatala, FAH Hainsworth, FA Howe, U Khan, C Kruuse, JB Madigan, B Moynihan, B Patel, AC Pereira, E Rostrup, ABY Shtaya, CA Spilling, S Trippier, R Williams, JD Isaacs, TR Barrick, AH Hainsworth. Translational Stroke Research (2022).